Andrew Charrette is a seasoned Regulatory Professional, serving as VP Regulatory Affairs at Wellbeing Digital Sciences and Director of Regulatory Affairs and Psychedelic Advisor at KGK Science Inc. With over 10 years experience in clinical development and regulatory consulting, Andrew has an in-depth knowledge of the nutraceutical, food, cannabis and drug regulations in North America. Andrew has led over 100 submissions to regulatory authorities including clinical trial applications and product registration submissions. Andrew has extensive experience in the design, planning, and execution of clinical trials across a wide spectrum of therapeutic indications and has most recently led several psychedelic clinical trial projects. He has provided guidance helping many companies navigate the regulatory landscape for nutraceutical, cannabis and psychedelic products in North America. Andrew received his undergraduate degree in Pharmacology and Physiology from the University of Western Ontario and later obtained a Master’s degree in Neuroscience from the University of Ottawa.